RADICAL CASEINOLYSIS IN AGAROSE: A SIMPLE METHOD FOR DETECTION OF PLASMINOGEN ACTIVATOR IN THE PRESENCE OF INHIBITORY SUBSTANCES AND SERUMSAKSELA O.1981; ANAL. BIOCHEM.; ISSN 0003-2697; USA; DA. 1981; VOL. 111; NO 2; PP. 276-282; BIBL. 26 REF.Article

Plasminogen activation and regulation of pericellular proteolysisSAKSELA, O.Biochimica et biophysica acta. 1985, Vol 823, Num 1, pp 35-65, issn 0006-3002Article

INCREASED SECRETION OF PLASMINOGEN ACTIVATOR BY HUMAN MACROPHAGES AFTER EXPOSURE TO LEUKOCYTE INTERFERONHOVI T; SAKSELA O; VAHERI A et al.1981; FEBS LETT.; ISSN 0014-5793; NLD; DA. 1981; VOL. 129; NO 2; PP. 233-236; BIBL. 24 REF.Article

SYNTHESIS AND SECRETION OF ALPHA-2-MACROGLOBULIN BY CULTURED ADHERENT HUNG CELLS. COMPARAISON WITH CELL STRAIN DERIVED FROM OTHER TISSUES.MOSHER DF; SAKSELA O; VAHERI A et al.1977; J. CLIN. INVEST.; U.S.A.; DA. 1977; VOL. 60; NO 5; PP. 1036-1045; BIBL. 37 REF.Article

Transforming growth factor β1 induces apoptosis in normal melanocytes but not in nevus cells grown in type I collagen gelALANKO, T; SAKSELA, O.Journal of investigative dermatology. 2000, Vol 115, Num 2, pp 286-291, issn 0022-202XArticle

CULTURED HUMAN SYNCYTIOTROPHOBLASTS SYNTHESIZE PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN (SP₁)HEIKINHEIMO M; SAKSELA O; LEHTOVIRTA P et al.1981; ACTA PATHOL. MICROBIOL. SCAND., SECT. C; ISSN 0304-1328; DNK; DA. 1981; VOL. 89; NO 2; PP. 139-144; BIBL. 19 REF.Article

INFLAMMATORY CELLS, IGA, C₃, FIBRIN AND FIBRONECTIN IN SKIN LESIONS IN DERMATITIS HERPETIFORMISREITAMO S; REUNALA T; KONTTINEN YT et al.1981; BR. J. DERMATOL. (1951); ISSN 0007-0963; GBR; DA. 1981; VOL. 105; NO 2; PP. 167-177; BIBL. 27 REF.Article

Local synthesis of plasminogen by the seminiferous tubules of the testisSAKSELA, O; VIHKO, K. K.FEBS letters. 1986, Vol 204, Num 2, pp 193-197, issn 0014-5793Article

DISTRIBUTION OF A MAJOR SURFACE-ASSOCIATED GLYCOPROTEIN, FIBRONECTIN, IN CULTURES OF ADHERENT CELLS.MOSHER DF; SAKSELA O; KESKI OJA J et al.1977; J. SUPRAMOLEC. STRUCT.; U.S.A.; DA. 1977; VOL. 6; NO 4; PP. 551-557; BIBL. 14 REF.Article

Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activitySAKSELA, O; RIFKIN, D. B.The Journal of cell biology. 1990, Vol 110, Num 3, pp 767-775, issn 0021-9525, 9 p.Article

Plasminogen activators during differentiation of the human kidneySAKSELA, O; HOLTHÖFER, H.Differentiation (London). 1987, Vol 34, Num 2, pp 131-138, issn 0301-4681Article

PRESENCE OF ALPHA ₂-MACROGLOBULIN IN NORMAL BUT NOT IN MALIGNANT HUMAN SYNCYTIOTROPHOBLASTSSAKSELA O; WAHLSTROM T; LEHTOVIRTA P et al.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 6; PP. 2507-2513; BIBL. 28 REF.Article

Cell-associated plasminogen activation: regulation and physiological functionsSAKSELA, O; RIFKIN, D. B.Annual review of cell biology. 1988, Vol 4, pp 93-126, issn 0743-4634Article

BASAL LAMINA COMPONENTS IN EXPERIMENTALLY INDUCED SKIN BLISTERSSAKSELA O; ALITALO K; KIISTALA U et al.1981; J. INVEST. DERMATOL.; ISSN 0022-202X; USA; DA. 1981; VOL. 77; NO 3; PP. 283-286; BIBL. 24 REF.Article

FGF expression allows nevus cells to survive in three-dimensional collagen gel under conditions that induce apoptosis in normal human melanocytesALANKO, T; ROSENBERG, M; SAKSELA, O et al.Journal of investigative dermatology. 1999, Vol 113, Num 1, pp 111-116, issn 0022-202XArticle

Transforming growth factor-β induction of type-1 plasminogen activator inhibitor: pericellular deposition and sensitivity to exogenous urokinaseLAIHO, M; SAKSELA, O; KESKI-OJA, J et al.The Journal of biological chemistry (Print). 1987, Vol 262, Num 36, pp 17467-17474, issn 0021-9258Article

Transforming growth factor β alters plasminogen activator activity in human skin fibroblastsLAIHO, M; SAKSELA, O; KESKI-OJA, J et al.Experimental cell research. 1986, Vol 164, Num 2, pp 399-407, issn 0014-4827Article

Regulation of plasminogen activator activity in human fibroblastic cells by fibrosarcoma cell-derived factorsSAKSELA, O; LAIHO, M; KESKI-OJA, J et al.Cancer research (Baltimore). 1985, Vol 45, Num 5, pp 2314-2319, issn 0008-5472Article

The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cellsSAKSELA, O; MOSCATELLI, D; RIFKIN, D. B et al.The Journal of cell biology. 1987, Vol 105, Num 2, pp 957-963, issn 0021-9525Article

Identification and localization of urokinase-type plasminogen activator in human NK-cellsCARPEN, O; SAKSELA, O; SAKSELA, E et al.International journal of cancer. 1986, Vol 38, Num 3, pp 355-360, issn 0020-7136Article

Presence of -2-macroglobulin in normal but not in malignant cervical epithelium = Présence d'alpha 2 macroglobuline dans l'épithélium du col de l'utérus normal mais non dans l'épithélium malinSAKSELA, O; WAHLSTROM, T; MEYER, B et al.Cancer research (Baltimore). 1984, Vol 44, Num 7, pp 2942-2946, issn 0008-5472Article

Urokinase-type plaminogen activator and its inhibitor secreted by cultured human monocyte-macrophagesSAKSELA, O; HOVI, T; VAHERI, A et al.Journal of cellular physiology. 1985, Vol 122, Num 1, pp 125-132, issn 0021-9541Article

Development of FGF-dependency in human embryonic carcinoma cells after retinoic acid-induced differentiationALANKO, T; TIENARI, J; LEHTONEN, E et al.Developmental biology (Print). 1994, Vol 161, Num 1, pp 141-153, issn 0012-1606Article

Tissue-type plasminogen activator-mediated activation of plasminogen on the surface of group A, C, and G streptotocciKUUSELA, P; ULLBERG, M; SAKSELA, O et al.Infection and immunity. 1992, Vol 60, Num 1, pp 196-201, issn 0019-9567Article

Increased expression of the matrix metalloproteinase 2 in differentiating Tera human embryonal carcinoma cellsTIENARI, J; PERTOVAARA, L; SAKSELA, O et al.International journal of cancer. 1994, Vol 56, Num 2, pp 219-223, issn 0020-7136Article